2022 Sponsorship Prospectus - EUFOREA
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
2022
Sponsorship Prospectus
1INVITATION TO PARTICIPATE
Dear Sponsor,
On behalf of the EUFOREA board and management team, we are delighted to present the 2022
Sponsorship Prospectus and invite you to explore the 2022 scientific programme. In 2022 you can
CONTENTS expect even more of EUFOREA's world-class continuing medical education events, a new augmented
reality platform bringing together experts from around the globe to engage in innovation debates,
and practical, evidence-based resources designed to engage HCPs and patients in a collaborative
partnership.
Invitation to Participate, Mission & Vision ...........2
EUFOREA is an international non-profit organization forming an alliance of all stakeholders dedicated
Who We Are.....................................................................3
to reducing the prevalence and burden of chronic respiratory diseases through the implementation of
optimal patient care via education, research and advocacy.
Sponsorship Opportunities......................................4
Thank you for your interest in collaborating with EUFOREA!
Pocket Guides & Patient Education Manuals.....5
2022 Educational Programme.................................6
Innovation Forum........................................................8 VISION
EUFOREA is an international non-profit organisation forming an alliance of all stakeholders dedicated
Strategic Partnership.................................................10 to reducing the prevalence and burden of chronic respiratory diseases through the implementation of
optimal patient care via education, research and advocacy.
Contacts.........................................................................11
MISSION
Based on its medical scientific core competency, EUFOREA offers a platform to introduce innovation
and education in healthcare leading to optimal patient care.
2Who We Are
Board of Directors
Prof. Dr. Peter Hellings Prof. Dr. Leif Bjermer Prof. Dr. Glenis Scadding Prof. Dr. Ulrich Wahn
Founder & Chairman Sweden United Kingdom Germany
Belgium
Expert Team Leads
Prof. Dr. Zuzana Diamant Prof. Dr. Ulrich Wahn Prof. Dr. Glenis Scadding Prof. Dr. Claus Bachert Prof. Dr. Wytske Fokkens Prof.Dr. Peter Nele Claeys
Asthma Paediatrics Rhinitis CRS EPOS Schmid-Grendelmeier Patient Advisory Board
The Netherlands Germany United Kingdom Belgium The Netherlands AIT Belgium
Switzerland
Management Team
Dr. Peter Walther Dr. Sunni Patel Amy Quinn Lindsay Cypers Elizabeth Van Staeyen Tania Rodrigues Lopes Anna Kapshyienko
Executive Director Academic Director Programme & Office Manager Marketing & Marketing & Project Officer
Germany United Kingdom Communications Manager Belgium Communications Specialist Communications Specialist Ukraine
United Kingdom U.S.A. Portugal 32022 Sponsorship Opportunities
RESEARCH EDUCATION ADVOCACY
Pocket Guides (HCPs) Launch of Global CRSwNP Awareness Day
MASTERCLASSES:
(based on novel treatment algorithms • Integrated Care for airways diseases (Q1)
developed by EUFOREA expert panel)
• Allergic Rhinitis and the atopic march (Q1) Lay Language Patient Education Manuals
• COVID19: a respiratory disease (Q1)
Topics for 2022 Include: Topics for 2022 Include:
• Training on upper airway disease evaluation
for non-ENT doctors (Q2) • Allergic Rhinitis in Adults
• Allergic Rhinitis in Adults • Pediatric Allergic Rhinitis
• Pediatric Allergic Rhinitis • Update on biologicals for CRSwNP and • Chronic Rhinosinusitis
• Chronic Rhinosinusitis Asthma (Q2) • Asthma
• Asthma • The Allergic Child: Update on current issues,
modern diagnosis and treatment (Q2) Self-assessment tool for patients (Allergic
• Upper & Lower Airways - methods/ Rhinitis, Chronic Rhinosinusitis and Asthma)
Screening tool for CRS and diagnostics/point of care biomarkers (Q2)
respiratory allergy (Consensus • Training on lower airways disease for non-
Statement) pulmonologists (Q3)
• Asthma: inhalational technique – small
airways – triple therapy (Q3)
• Allergic Rhinitis NOW (Q3)
• Biologicals in Asthma & CRS (Q4)
INNOVATION FORUM:
• All you ever wanted to know about Covid but
didn't dare to ask (Q1)
• Science (or) fiction of e-health in respiratory
field (Q2)
• Non-surgical nose surgery (Q3)
• Improved coordination of care in type 2
inflammation (Q4)
PATIENT EDUCATION WEBINAR:
4 • Allergic Rhinitis (Q3)Introducing Strategic Partnerships
We are proud to be able to work with our strategic partners to provide world-leading activities and work closely together to shape awareness and
education around the management of allergies and airway diseases.
A strategic partnership allows forward planning of bespoke events and initiatives that can be disseminated and used globally to make an impact
on change in patient care.
From webinars, masterclasses, patient initiatives and guides a strategic partner gets a first glance and opportunity to partner with EUFOREA on
unique and often first to market initiatives as well as meet with our world leading board and expert leads as part of an exclusive network.
We believe that EUFOREA's network of key opinion leaders in the field of chronic respiratory diseases can accelerate change and implement novel
solutions so that patients suffering from CRDs have access to timely, effective treatment. By forming an alliance with EUFOREA as a strategic
partner, your organization is granted access to:
Scientific Projects & Educational Events Advocacy Exclusive Access
• Priority participation in scientific projects • Support of patient advocacy projects - • Twice a year talks of board/MT and
of EUFOREA burden of disease strategic partners about situation of
• Opportunity to launch scientific projects • Initiate and support public campaigns - patient treatment and strategies and
in collaboration with EUFOREA proper diagnosis opportunities to optimise treatment and
• Priority to participate actively in • Leverage aligned key messages through raise awareness.
new products/events (E.g. EUFOREA combined communication • Discuss EUFOREA agenda
Innovation Forum) • Brainstorm common action of all strategic
partners to raise patient and/or political
awareness
• Strategic Partner Brand
EUFOREA appreciates the continued support of
our 2022 strategic partners:
5Pocket Guides & Patient Education Manuals
Simultaneously support healthcare providers and patients with the EUFOREA Pocket Guides
and Patient Education Manuals
Pocket Guides (for HCPs) Patient Education Manuals SPONSORSHIP INCLUDES:
• Sponsor logo with hyperlink to company website
The EUFOREA pocket guide series EUFOREA Patient Education Manuals
has been designed to provide featured on EUFOREA homepage
aim to provide a trustworthy, simple
comprehensive, evidence-based patient resource to empower patients
treatment guidelines for chronic with Rhinitis, Rhinosinusitis, or Asthma • Development of co-branded pocket guide and/or
respiratory diseases - all in the palm to help them decode their medical patient education manual featuring EUFOREA logo &
of your hand. The Pocket Guides condition in an effort to better outcomes sponsor logo with acknowledgment text on back cover
from EUFOREA have been developed of treatment, better understanding of
to offer guidance for all patient preventive aspects and with more cost • Unlimited number of interactive digital pocket guides
phenotypes as they appear in the savings for healthcare systems. available as an e-book to share with providers in your
physician's office in the real world. organisation (for private use only)
• Option for individual purchase of physical version
2022 Topics (click to view preview) printed and shipped on demand.
• Scientific “Letter to the editor” on the treatment algorithm
Allergic Rhinitis (Adult) behind the pocket guide in peer reviewed journal (see
example here)
Allergic Rhinitis (Paediatric)
• Social media acknowledgment of sponsorship on
Chronic Rhinosinusitis EUFOREA social media platforms: Twitter, LinkedIn,
Facebook (3 posts)
Asthma
• Recognition in one EUFOREA Breaking News Interview
(see example here)
Click to View Sample • Dissemination via the EUFOREA Newsletter (distributed
to 7K registered users)
Available as either individual guide(s) or package of
Pcoket Guide + Patient Education Manual on selected topic. • Option for translation into local language(s)
62022 EUFOREA Educational Events
In a fast-paced and changing world EUFOREA now makes it easier than ever to deliver virtual CME-accredited event on the latest
innovation in allergies and airways disease care.
OPTION 1: EUFOREA Initiated Programme
MASTERCLASSES MASTERCLASSES
• Integrated Care for airways diseases • Training on upper airway disease evaluation for
Q1 • Allergic Rhinitis and the Atopic March Q2 non-ENT doctors
• Update on biologicals for CRSwNP and Asthma
INNOVATION FORUM: • Upper & Lower Airways - methods/diagnostics/
• All you ever wanted to know about Covid point of care biomarkers
but didn't dare to ask • The Allergic Child: Update on current issues,
modern diagnosis and treatment
MASTERCLASSES: INNOVATION FORUM:
• Training on lower airways disease for • Science (or) fiction of e-health in respiratory
non-pulmonologists field
• Asthma: inhalational technique – small
airways – triple therapy
Q3 • Allergic Rhinitis NOW MASTER CLASS: Biologicals (Asthma & CRS)
INNOVATION FORUM: Q4 INNOVATION FORUM: Improved
• Non-surgical nose surgery coordination of care in Type 2 inflammation
PATIENT EDUCATION WEBINAR:
• Allergic Rhinitis
7OPTION 2: Sponsor Initiated EUFOREA Programme MARKETING & COMMUNICATIONS PACKAGE:
(Note: All content is developed independently by EUFOREA expert teams)
■ Placement of sponsor logo with hyperlink to website on the
EUFOREA events page
You select a title & EUFOREA will develop a ■ Positioning of sponsor logo and acknowledgement by
agreement on all print & digital materials including event save
CME-positioned webinar the date and webinar slide
Partners can count on EUFOREA to provide educational events developed ■ Dissemination of save the date and sponsor acknowledgement
with the most relevant, updated, and evidence-based guidelines. in The EUFOREAN newsletter (7K subscribers)
■ Webinars available on-demand on the EUFOREA webinar
Bring your vision to life with EUFOREA's network of world renowned
plaform for 6 months following the event
faculty, broadcast-quality AV facilities (live moderation and Q&A,
polling, CME application), professional marketing & communication ■ Recognition on EUFOREA social media channels:
package and comprehensive evaluation package.
EVALUATION PACKAGE:
Click here to submit your programme proposal
Number and nationality of registered participants
(broken down into regions and countries),
Live viewing statistics of participants and duration
viewing of a webinar series.
Who Attends?
Supplements:
Otorhinolaryngologists
■ Closed captioning and/or live voice translation in local
Allergologists language(s)
Immunologists,
Pulmonologists ■ Pocket Guide + feature during live event on related topic
Medical Residents (AR/Asthma/CRS)
8NEW!
Innovation Forum
Balanced roundtable debates in EUFOREA's augmented reality studio offer a forum for all stakeholders to engage in open
discussion about innovation in respiratory care.
The EUFOREA Innovation Forum is a new type of virtual event that will offer
balanced debates featuring multidisciplinary stakeholders including medical
scientists, physicians, patients, payers and healthcare industry representatives
on topics related to innovation.
EUFOREA believes that the way to shape the future of chronic respiratory
care is through collaboration with all stakeholders working on respiratory
disease. This includes discussion and promotion of innovative prevention &
care strategies that improve patients' quality of life through optimal care and
control of disease. This augmented reality studio facility offers a platform for
live-streamed and recorded debates.
INNOVATION FORUM TOPICS FOR 2022 INCLUDE:
Click photo above to preview
EUFOREA's augmented reality set! ■ Q1: All you ever wanted to know about Covid but didn't
dare to ask
■ Q2: Science (or) fiction of e-health in respiratory field
■ Q3: Non-surgical nose surgery
■ Q4: Improved coordination of care in Type 2 inflammation
9SPONSORSHIP INCLUDES:
• Full - service organisation of a debate of 1 hr with up to 5
participants around novel topic as augmented reality show
which is moderated, recorded and edited by a professional medical
journalist.
• Preparation of storyboard by EUFOREA Board, Expert Team and
optionally external experts. Discussion panel with up to 5 experts of
different disciplines.
• One industry representative in discussion may be chosen by Live interaction between between host & participants!
Sponsor.
• Evaluation Package
• Marketing & Communication Package before and after
publication, including:
Acknowledgment on EUFOREA social media channels
Twitter, Linkedin, Facebook (4 posts)
1 Breaking News Interview
Sponsor logo with hyperlink to website on EUFOREA Homepage
and EUFOREA Newsroom
Acknowledgment of sponsorship in 2 EUFOREA newsletters
Hosted by professional medical journalist
• Optional: Publication possible as printed version of e.g. debates of
2021 or 2022
10CONTACT US!
For more information about sponsorship opportunities
available with EUFOREA, submit your programme
proposal or to learn how you can become a Strategic
Partner, please contact:
Dr. Sunni Patel
Academic Director
Phone: +44 7910 765440
Email: Sunni.Patel@euforea.eu
Elizabeth Van Staeyen
Marketing & Communications Specialist
Phone:+32 488597832
Email:Elizabeth.Vanstaeyen@euforea.eu
11INSPIRING THE FUTURE CARE OF
ALLERGIES AND AIRWAY DISEASES
EUFOREA is an international non-profit organisation forming an alliance of
all stakeholders dedicated to reducing the prevalence and burden of chronic
respiratory diseases through the implementation of optimal patient care through
research, education and advocacy.
132 Blvd Brand Whitlock, 1200 Brussels, Belgium
www.euforea.euYou can also read
